
Pablo Sebastián Muñoz Schuffenegger
Profesor Asociado
Pontificia Universidad Católica de Chile
Santiago, Chile
Radiation Oncology. Stereotactic Body Radiation Therapy. Gastrointestinal malignancies. Lung Cancer. Imaging- and blood-based biomarkers
-
Médico Cirujano, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2009
-
Radioterapia Oncológica, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 2013
-
High Precision Radiation Therapy, UNIVERSITY OF TORONTO. Canada, 2018
-
Instructor Adjunto Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Medicina
Santiago, Chile
2013 - 2019
-
Profesor Asistente Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Medicina
Santiago, Chile
2019 - 2024
-
Profesor Asociado Full Time
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
Medicina
Chile
2024 - A la fecha
-
Radio Oncólogo Full Time
Centro de Cáncer Universidad Católica
Santiago, Chile
2013 - 2015
-
Clinical Fellow Full Time
University of Toronto
Toronto, Canada
2015 - 2018
-
Radio - Oncólogo Full Time
Centro de Cáncer Universidad Católica
Santiago, Chile
2018 - A la fecha
-
International Journal of Radiation Oncology, Biology, and Physics - Resident Peer Reviewer Training Program
American Society of Therapeutic Radiology and Oncology
Estados Unidos, 2017
Resident Peer Reviewer Training Program
-
International Academy Award
International Association for the Study of Lung Cancer (IASLC)
Estados Unidos, 2017
International Association for the Study of Lung Cancer (IASLC) International Academy Award
-
KCRNC – CUOG Trainee Award
Kidney Cancer Research Foundation of Canada
Canada, 2017
Research Trainee Award
-
Inaugural Cancer Program Best Fellow Award
UNIVERSITY OF TORONTO
Canada, 2018
Inaugural Cancer Program Best Fellow Award
-
Excellence in Education by a Trainee Award
University Health Network (UHN) - Radiation Medicine Program, Princess Margaret Cancer Centre
Chile, 2019
Excellence in Education by a Trainee Award
What Is the Optimal Radiotherapy Utilization Rate for Lung Cancer? a Systematic Review |
Stereotactic Body Radiation Therapy for Gastrointestinal Cancers |
What is the optimal radiotherapy utilization rate for lung cancer? -a systematic review |

Bruno Nervi
Associated Professor
Hematology - Oncology
Pontificia Universidad Catolica de Chile
Santiago, Chile

Francisco Acevedo
Medico Oncologo
Hemato Oncologia
Pontificia Universidad Católica de Chile
Santiago, Chile

Pablo Muñoz
Profesor Asociado
Hematología-Oncología
Pontificia Universidad Católica de Chile
Santiago, Chile